Drug prices One policy replaces legal shields for current rebates from drug manufacturers to pharmacy middlemen with protections for new, fixed arrangements that untie the payment amount from the price of the drug. (Photo: Shutterstock)

(Bloomberg) –The Trump administration Friday released two contentious drug policies, one that could cut profit margins for pharmaceutical companies and another that would allow them to make smaller payments to their partners.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.